Table 1.
ATC code | PPI name | Strength classification* | mg | PBS subsidized indications |
---|---|---|---|---|
A02BC01 | omeprazole | Standard | 20 | PU, GORD, SO, ZES |
Low | 10 | GORD, SO, ZES | ||
A02BC02 | pantoprazole | Standard | 40 | PU, GORD, SO, ZES |
Low | 20 | GORD, SO, ZES | ||
A02BC03 | lansoprazole | Standard | 30 | PU, GORD, SO |
Low | 15 | GORD, SO | ||
A02BC04 | rabeprazole | Standard | 20 | PU, GORD, SO |
Low | 10 | GORD, SO | ||
A02BC05 | esomeprazole | High | 40 | GORD, SO, Pathological hypersecretory conditions including ZES and idiopathic hypersecretion |
Standard | 20 | GU, GORD, SO, Pathological hypersecretory conditions including ZES and idiopathic hypersecretion |
Strength classification is based on guidelines by Therapeutic Guidelines Ltd. and the National Institute for Health and Care Excellence (NICE 2014): Guideline (CG184).
ATC, anatomical therapeutic chemical; GORD, Gastro-oesophageal reflux disease; GU, Gastric Ulcer; PBS, Pharmaceutical benefits scheme; PPI, proton-pump inhibitors; PU, Peptic Ulcer; SO, Scleroderma oesophagus; ZES, Zoillinger–Ellison syndrome.